Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
155.6 EUR | +0.65% | -.--% | -.--% |
06/05 | BALOISE HOLDING : EPS cut (2023: -25.7%, 2024: -19.8%) | |
06/05 | CAC 40: towards a quiet week due to public holidays | CF |
Summary
- On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.
- From a short-term investment perspective, the company presents a deteriorated fundamental configuration.
Strengths
- Growth progress expectations are rather promising. Indeed, sales are expected to rise sharply in the coming years.
- The company is one of the best yield companies with high dividend expectations.
- Growth remains a strong point in this company. In their sales forecast, analysts sound optimistic with regard to sales prospects.
- The opinion of analysts covering the stock has improved over the past four months.
- Over the past twelve months, analysts' opinions have been strongly revised upwards.
- The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
Weaknesses
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
- Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.
Ratings chart - Surperformance
Sector: Multiline Insurance & Brokers
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-.--% | 7.29B | - | ||
+12.57% | 103B | C+ | ||
+8.51% | 101B | B | ||
+3.32% | 72.63B | C+ | ||
+26.71% | 30.13B | A- | ||
+7.04% | 19.39B | A- | ||
+0.59% | 12.65B | B- | ||
+11.02% | 11.33B | A- | ||
+13.79% | 11.05B | A | ||
+18.59% | 9.8B | A- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- BALN Stock
- BLON Stock
- Ratings Bâloise Holding AG